Brief: Immunovia: Q2 Cash Flow From Operating Activities Down At SEK -26.7 Mln
05/08/2024 07:38
Aug 5 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* WE CONTINUE TO LIMIT OVERALL OPERATING EXPENSES TO
PRESERVE
CASH; CASH FLOW FROM OPERATING ACTIVITIES WAS SEK -26.7 MILLION,
DOWN 38% COMPARED TO Q2 2023
Source text for Eikon: ID:nWkrbF1pXy
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study